GLP-1 receptor agonists may reduce alcohol cravings and intake.
They show promise for both moderation and abstinence treatment goals.
These medications may also improve coexisting conditions like obesity or diabetes.
GLP-1s are best used alongside behavioral therapies-not as standalone treatments.